Cyclic Vomiting Syndrome Clinical Trial
A Comparison of Haloperidol 5mg IM vs Droperidol 2.5mg and Ondansetron for the Treatment of Hyperemesis in Cyclic Vomiting Syndrome
The purpose of this study is to compare two commonly used agents for the treatment of cyclic vomiting to see if one agent is inferior to the other in time to improvement in symptoms, need for repeat or rescue medications, treatment failures and complications/side effects.
|Source||Spectrum Health - Lakeland|
|Start date||August 30, 2021|
|Completion date||August 2022|
|Active, not recruiting||